|
|
|
Journal of Bacteriology, July 2002, p . 3992-4002, Vol . 184, No . 14 A Repressor Protein, PhaR, Regulates Polyhydroxyalkanoate (PHA) Synthesis via Its Direct Interaction with PHA
Akira Maehara,1, Polymer Chemistry Laboratory, RIKEN Institute, 2-1 Hirosawa, Wako-shi, Saitama 351-0198,1 Laboratory of Molecular Biotechnology, Division of Molecular Cell Mechanisms, Department of Biological Mechanisms and Functions, Graduate School of Bioagricultural Sciences, Nagoya University, Chikusa-ku, Nagoya, 464-8601,2 Department of Innovative and Engineered Materials, Tokyo Institute of Technology, 4259 Nagatsuta, Midori-ku, Yokohama 226-8502, Japan3 Received 11 January 2002/ Accepted 4 April 2002
Phasins are the most dominant proteins of relatively small molecular size that are associated with PHA granules . It has been proposed that phasins form an amphiphilic layer between the PHA granule and cytoplasm in a manner similar to that of oleosins, which form a layer at the surface of triacylglycerol inclusion in oilseed plants (32, 33, 42, 49) . These lipid-body-associated proteins exist in several organisms (for a recent review, see reference 30) . Phasins also affect the size and the number of PHA granules (15, 16, 49) and positively affect PHA synthesis (8, 15, 26, 32, 33, 36, 40, 42, 49, 53) . The production of phasin in Ralstonia eutropha (formerly designated Alcaligenes eutrophus) is suggested to be dependent on the presence of an intact PHA synthesis apparatus, although the mechanism of their regulation is unknown (49) . This phenomenon was confirmed rigorously by using several phaC and phaP deletion-replacement mutant strains of R . eutropha (52) . The amount of phasin in the cells was also found to be proportional to the content of PHA in P . denitrificans (26) . In a heterologous expression experiment in Escherichia coli, overexpression of PhaP occurred in the absence of phaR, while PhaP expression was strongly repressed in the presence of phaR without poly[(R)-3-hydroxybutyrate] [P(3HB)] production . However, expression of PhaP was observed in E . coli even in the presence of phaR when P(3HB) was produced under carbon-rich conditions (26) . Genes that encode proteins homologous to PhaR have been found in pha loci from many SCL PHA-producing bacteria (24, 26) . In our previous studies, we found that PhaR is a 22-kDa protein which is able to bind to the upstream regions of both phaP and phaR of P . denitrificans (24) . The ability of PhaR to bind to DNA and its regulatory function for PhaP expression in vitro were analyzed by using purified recombinant PhaR produced by E . coli (24) . However, little is known about the detailed regulatory mechanism of PhaR in PHA metabolism (17, 24, 26) . Most recently, it was shown that PhaR was involved in P(3HB) synthesis via PhaP expression in vivo, using a phaR knockout mutant of R . eutropha (54) . To gain a new insight into the role of PhaR in PHA synthesis, we have analyzed the function of the PhaR protein in more detail . In this paper, we determined the distinct target DNA sequences for PhaR binding and further demonstrated that PhaR binds to not only DNA but also PHA . We found evidence that P(3HB) acts as an inducer for phaP expression in a PhaR-mediated regulatory system . This report also presents direct evidence that PhaR interacts with PHA via direct binding . Furthermore, our observations may raise the possibility that the PhaR-mediated regulatory mechanism in response to PHA accumulation in cells is common in SCL PHA-producing bacteria .
Production and purification of PhaR.
PhaR was purified as previously described (24), with some modifications . E . coli BL21(DE3) cells harboring recombinant plasmid pTV119N::phaR were grown at 37°C for 13 h in 500 ml of LB medium . Cells were harvested by centrifugation (8,000 x g; 5 min; 4°C), washed, suspended in T buffer (20 mM Tris-HCl [pH 7.5]), recentrifuged, resuspended in 10 volumes of TEP buffer (20 mM Tris-HCl [pH 7.5]), 1 mM EDTA, 1 mM phenylmethylsulfonyl fluoride), and then disrupted by two passages through a French press (138 MPa) . Unbroken cells and cellular debris were removed by centrifugation (10,000 x g; 60 min; 4°C), and solid ammonium sulfate was added to the supernatant to 10% saturation . After removing the precipitate, ammonium sulfate was added again to the supernatant to 30% saturation . The precipitates were collected by centrifugation (10,000 x g; 20 min; 4°C), dissolved in 6 ml of P buffer (20 mM potassium phosphate [pH 7.5]), and dialyzed against the buffer . The sample was overloaded onto a column (26 by 100 mm) of phosphocellulose (Whatman P11) previously equilibrated with P buffer . The tailing fractions followed by a compact peak containing most proteins were collected, added to ammonium sulfate (20% saturation), and loaded onto a butyl-Sepharose column (25 ml; Amersham Pharmacia Biotech, Piscataway, N.J.) previously equilibrated with PA buffer (20 mM potassium phosphate [pH 7.5], 1 M ammonium sulfate) . After washing the column with PA buffer, PhaR was eluted within a stepwise gradient of 1 to 0 M ammonium sulfate . Fractions containing PhaR were collected, diluted 10-fold with 10 mM Tris-HCl (pH 7.5), and loaded onto a Resource Q column (6 ml; Amersham Pharmacia Biotech) previously equilibrated with T buffer . After washing the column with T buffer, PhaR was eluted within a linear gradient of 0 to 0.5 M NaCl . The purified fractions were combined, dialyzed against T buffer, and stored . Protein concentrations were determined from the absorbance at 280 nm . The molar extinction coefficient at 280 nm ( Analytical procedures for PhaR. Matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS) analysis of PhaR was performed on a REFLEX apparatus (Bruker-Franzen Analytik, Bremen, Germany) with sinapinic acid as a matrix . Dynamic light scattering (DLS) was performed in a DynaPro-801 DLS instrument (Protein Solutions Inc., Charlottesville, Va.) at 25°C using purified PhaR (1.12 mg/ml in 20 mM Tris-HCl [pH 7.5]) . DNase I footprinting experiment. DNase I footprinting using infrared dye was performed by the method described by Machida et al . (22) . DNA fragments containing PhaR-binding sites were prepared by PCR using 50 ng of plasmid pTVCP4, containing the phaP and phaR promoter regions, as template . IRD800 dye-labeled custom primers were made by Aloka (Tokyo, Japan) . A combination of 5'-biotinylated and 5'-IRD800-labeled primers were used to introduce biotin and IRD800 fluorescent dye at different ends of the DNA fragments . The fragments were analyzed by electrophoresis on an agarose gel before use and were densitometrically quantitated after ethidium bromide staining with an ATTO Lane & Spot Analyzer equipped with a UV transilluminator (Atto) . After purification by gel filtration (MicroSpin S-400 HR; Amersham Pharmacia Biotech), the biotinylated IRD800-labeled DNA fragments were immobilized on streptavidin-coated paramagnetic beads (Dynabeads M-280-Streptavidin; Dynal, Oslo, Norway) according to the manufacturer's specifications . The immobilized fragment (ca . 25 to 200 fmol) was mixed with PhaR (ca . 1 to 25 µg) in 100 µl of buffer (25 mM HEPES-NaOH [pH 7.8], 50 mM KCl, 0.05 mM EDTA, 0.5 mM dithiothreitol, 0.5 mM phenylmethylsulfonyl fluoride, and 5% glycerol) at 25°C for 30 min . After addition of MgCl2 (final concentration, 5 mM) and DNase I (7.5 x 10-3 U), the reaction mixture was incubated for 1 min at 25°C and then quenched by addition of 1 volume of ice-cold stop buffer (4 M NaCl, 0.1 M EDTA [pH 8.0]) . After washing the beads with BW buffer (10 mM Tris-HCl [pH 7.5], 1 mM EDTA, 2 M NaCl), the beads were suspended in 1.5 µl of loading buffer (95% formamide, 10 mM EDTA [pH 7.6], 0.1% bromophenol blue) . Samples for a DNA ladder were prepared by the dideoxy chain termination method using 5'-IRD800-labeled primers with a Thermo Sequenase fluorescent-labeled primer cycle sequencing kit with 7-deaza-dGTP (Amersham Pharmacia Biotech) . The samples were denatured at 95°C for 2 min, loaded on a sequencing gel (25-cm length, containing 5.5% Long Ranger [FMC BioProducts], 7 M urea, 0.6x Tris-borate-EDTA [TBE] buffer, 0.5x TBE running buffer), and electrophoresed by using a LI-COR 4000L sequencer with BaseImagIR version 4.0 (LI-COR, Lincoln, Nebr.) . Preparation of native PHA granules. Poly[(R)-3-hydroxyvalerate] [P(3HV)] granules from P . denitrificans were obtained from cells that were cultivated for 24 h at 30°C in a 300-ml flask in inorganic salt medium containing 0.1% (vol/vol) n-pentanol . P(3HB) granules from E . coli XL1-Blue(pBBRKmAB pTVC) or XL1-Blue(pBBRKmAB pTVCP4) were obtained from cells that were cultivated for 30 h at 37°C in a 100-ml flask culture in LB medium supplemented with 2% sodium lactate . PHA [P(3HB-co-3HV)] granules from R . eutropha were prepared from cells that were cultivated for 55 h at 30°C in a 100-ml flask in a nitrogen-limited mineral salt medium (28) supplemented with 1% fructose and 0.5% sodium pentanoate (0.1% sodium pentanoate was added to the medium five times) . The cells were harvested by centrifugation (8,000 x g; 10 min; 4°C), washed, resuspended in 3 volumes of 50 mM Tris-HCl (pH 7.5), and then disrupted by two passages through a French press (138 MPa) . After centrifugation (10,000 x g; 30 min; 4°C), the precipitate was suspended in 50 mM Tris buffer . Approximately 200 to 500 µl of the suspension was layered on a discontinuous sucrose gradient consisting of 1 ml each of 2.00, 1.67, 1.33, and 1.00 M sucrose in 50 mM Tris buffer . After centrifugation (210,000 x g; 2.5 h; 4°C), the PHA granule condensed layer was isolated . The native granules were then washed twice with 50 mM Tris buffer, resuspended in the same buffer, and stored at -20°C . Preparation of artificial PHA granules. Crystalline P(3HB) granules prepared by the hypochlorite detergent method were purchased from ICI . Artificial amorphous P(3HB) granules were prepared from crystalline P(3HB) by the method described by Horowitz and Sanders (12), using sodium oleate as a surfactant (37) . Preparation of 3HB oligomers by alkaline hydrolysis. The single crystals of P(3HB) were grown from dilute solution according to a method derived from that of Marchessault et al . (27) . For 3HB oligomer preparation, the single crystals of P(3HB) were hydrolyzed by sodium hydroxide solution according to a method previously described (14) . For alkaline hydrolysis, P(3HB) single crystals were collected by centrifugation, washed once with distilled water, and resuspended in 0.1 N sodium hydroxide solution . The crystals were hydrolyzed at 37°C for about 16 to 24 h . This solution was not shaken, in order to prevent the single crystals from breaking . The degraded single crystals consisting of 3HB oligomers were washed three times with distilled water to remove the sodium hydroxide solution . The 3HB oligomers were then redispersed in methanol, washed twice by centrifugation, and resuspended in dimethyl sulfoxide . The number-average molecular weight of the prepared 3HB oligomers was about 2 x 103 to 3 x 103, indicating that the 3HB oligomers were approximately 30-mers . Preparation of antibody. The purified PhaR protein (about 1 mg) was mixed with Freund's complete adjuvant and injected into a rabbit . Before sensitization to PhaR, a small quantity of serum was prepared from the rabbit . Two weeks after the first sensitization to PhaR, the antigen was again injected into the rabbit, with Freund's incomplete adjuvant . After 3 weeks, immune serum with high immunity toward PhaR antigen was prepared from the rabbit and used for several immunological assays . Western blot analysis. Western blotting was done as described by Burnette (5) with cellulose nitrate membrane or polyvinylidene difluoride membrane . In the immunoblot analysis, peroxidase-conjugated anti-rabbit immunogloblin G (Bio-Rad Laboratories) was used as the secondary antibody . The blot was developed with 4-chloro-1-naphthol (39) . Estimation of the ratios of PhaP and PhaR to total PHA granule-associated proteins from P . denitrificans. The ratios of PhaR and PhaP to total PHA granule-associated proteins from P . denitrificans were determined by densitometric scanning of SDS-PAGE gels stained with CBB . When large amounts of granule-associated proteins were applied to the gel for staining PhaR with CBB, the intensity of the band corresponding to PhaP was already saturated . Because of this saturation, other SDS-PAGE gels handled with exponentially increasing amounts of granule-associated proteins were compared to one another . The contents of PhaR and PhaP were estimated by extrapolating to the obtained intensities . Rebinding of PhaR to two different P(3HB) granules. The two kinds of P(3HB) granules (5 mg), crystalline and artificial amorphous, were independently incubated for 30 min at 4°C with supernatant of crude lysate [in 1 ml of TE buffer (10 mM Tris-HCl, pH 8.0; 1 mM EDTA)], corresponding to 10 ml of cells of an E . coli BL21(DE3) strain culture expressing phaR . A control experiment was carried out in parallel with crude lysate prepared from the strain bearing the plasmid vector only (pTV119N) . After the incubation, granules were collected by centrifugation, washed twice with 200 µl of TE buffer, and resuspended in denaturing buffer . P(3HB) granule-associated proteins and the crude lysates were analyzed by SDS-15% PAGE . Gel mobility shift assay using candidate effector molecules. To determine the effector molecule(s) for PhaR, a gel mobility shift assay in the presence of substances related to P(3HB) metabolism was carried out by the method described previously (24) with some modifications . The DNA fragments used for the gel mobility shift assay were prepared by digesting plasmid pTVCP4 with SalI and SmaI to give 225-, 276-, 407-, 639-, and 4,873-bp fragments (see Fig . 4, lane 1) . The resulting DNA fragments (2 µg) were mixed with PhaR (158 ng) in binding buffer (10 mM Tris-HCl [pH 7.5], 1 mM EDTA, 80 mM NaCl, 4% glycerol) in a total volume of 20 µl . The water-soluble metabolites free CoA, acetyl-CoA, acetoacetyl-CoA, (R)-3-hydroxybutyryl-CoA, (S)-3-hydroxybutyryl-CoA, (rac)-3-hydroxybutyric acid (3HB), (R)-3HB-dimer, NAD+, NADH, NADP+, NADPH, acetyl phosphate, citric acid, and phosphoenolpyruvate were each used at a 1 mM concentration . Polyphosphate (final concentration, 0.2 µg/µl) was also tested . Insoluble P(3HB) derivatives, namely, crystalline P(3HB) granules, artificial amorphous P(3HB) granules, and 3HB oligomers (approximately 30-mer), were also tested in this assay . Native PHA granules and partially purified PhaP were also used .
Cell-free protein synthesis. Cell-free protein synthesis using the E . coli S30 extract system for circular DNA (Promega, Madison, Wis.) was carried out as recommended by the manufacturer, with some modifications . The template DNA vectors used were pPDPK1.7 carrying the phaP gene and pTV119N (as a negative control) (24) . PhaR was added to the reaction mixtures before addition of template DNA . A 1-µl suspension of crystalline P(3HB) granules (0.1 mg/µl) was added to the reaction mixture in the presence of P(3HB) . Determination of cell-free protein synthesis was performed by adding 4 µg of plasmid DNA to the total volume of 50 µl at 37°C for 60 min and stopping synthesis by adding 200 µl of cold acetone . The precipitates were collected by centrifugation (10,000 x g; 10 min; 4°C) and dissolved in 200 µl of 1x SDS-PAGE sample buffer . After denaturation of proteins (100°C, 5 min), the translation products were separated by an SDS-12.5% PAGE and analyzed by Western blotting .
Database searches and sequence alignments.
Nucleotide sequences potentially coding for proteins similar to PhaR were searched among both GenBank and the unfinished microbial genomes database available on the National Center for Biotechnology Information web page (http://www.ncbi.nlm.nih.gov/Microb_blast/unfinishedgenome.html) using the BLAST alignment program (1) . Preliminary sequence data for Burkholderia fungorum, Chloroflexus aurantiacus, Desulfitobacterium hafniense, Magnetococcus sp . MC-1, Magnetospirillum magnetotacticum, Ralstonia metallidurans, Rhodobacter sphaeroides 2.4.1, Rhodopseudomonas palustris, and Sphingomonas aromaticivorans were obtained from the DOE Joint Genome Institute at http://www.jgi.doe.gov/JGI_microbial/html/index.html . Bordetella bronchiseptica, Bordetella parapertussis, Bordetella pertussis, and Burkholderia pseudomallei sequences were produced by the respective sequencing groups at The Sanger Institute (http://www.sanger.ac.uk/) . Preliminary sequence data for Burkholderia mallei were obtained from The Institute for Genomic Research website at http://www.tigr.org . The Legionella pneumophila sequence was obtained from the Legionella Genome Project (http://genome3.cpmc.columbia.edu/
Identification of PhaR-binding regions of DNA. Previously, it was demonstrated that PhaR is a DNA-binding protein which blocks phaP expression in vitro (24) . The binding sites of PhaR were suggested to be both the phaC-phaP intergenic region (designated IRCP) and the phaP-phaR intergenic region (designated IRPR) (24) . To more precisely determine PhaR-binding sites, DNase I footprinting experiments were performed on both IRCP and IRPR, as shown in Fig . 1 . The PhaR-binding site in IRCP was shown to have a 56-bp core sequence which overlaps the putative phaP promoter region (Fig . 1A, B, and E) . PhaR appeared to protect a 23-bp sequence which partially overlaps the putative phaR promoter region in IRPR (Fig . 1C, D, and F) . Several repeated TGC sequences were shared by both intergenic regions and protected against DNase I digestion . These results suggested the presence of a common motif which includes the repeated TGC sequences (designated the TGC-rich region) . In IRCP, two TGC-rich regions (TGC I and TGC II) were found (Fig . 1E), whereas one TGC-rich region (TGC III) was found in IRPR (Fig . 1F) . A gel mobility shift assay revealed that PhaR binding affinity toward IRCP was higher than that towards IRPR by about 1 order of magnitude (data not shown) . This difference in the binding affinities may be due to the difference in the number of TGC-rich regions within each motif .
Existence of PhaR on native PHA granules in vivo. We assumed that PhaR is a PHA-responsive repressor, based on the following findings: (i) PhaR homologs have been found in many SCL PHA-producing bacteria (24); (ii) PhaP production seems to be regulated by the presence of phaR in response to P(3HB) production in vivo (26); (iii) PhaR can bind the upstream regulatory sequences for phaP and phaR (Fig . 1; see also reference 24) . To examine the localization of PhaR in vivo, SDS-PAGE and Western blotting were carried out for soluble proteins and PHA granule-associated proteins from P . denitrificans, R . eutropha, and two PHA-producing recombinant E . coli XL1-Blue strains carrying phaAB-phaC or phaAB-phaCPR . To further address the function of PhaR, two strains of recombinant E . coli were prepared . One carries pBBRKmAB and pTVC [only for P(3HB) generation], and the other carries pBBRKmAB and pTVCP4 (in coexistence with the regulated PhaP production system) (26) . These two E . coli strains were individually cultivated in LB medium (with ampicillin and kanamycin) supplemented with sodium lactate as an excess carbon source to produce P(3HB) . P . denitrificans was cultivated in inorganic medium supplemented with n-pentanol to accumulate P(3HV) . R . eutropha was grown in mineral salts medium supplemented with both fructose and sodium pentanoate to produce P(3HB-co-3HV) . The results are shown in Fig . 2 .
Interestingly, it was demonstrated that a protein ( PHA granule-associated proteins from P . denitrificans. The ratios of PhaR and PhaP to total PHA granule-associated protein from P . denitrificans were estimated to be 0.3% ± 0.1% and 96%, respectively, by densitometric scanning of SDS-PAGE gels stained with CBB (Fig . 2E) . The presence of PHA synthase (PhaC) and PHA depolymerase (PhaZ) in the PHA granule-associated proteins was also revealed by the immunological analysis for PhaC and N-terminal amino acid sequence analysis for PhaZ (data not shown) . Figure 2E shows that PhaR exists on native PHA granules from P . denitrificans, although PhaR is not a predominant PHA granule-associated protein . Rebinding of PhaR to P(3HB) granules. It was of interest to investigate how PhaR recognizes and tightly binds to PHA granule . A PhaR binding experiment was performed in vitro using two different P(3HB) granules, crystalline and artificial amorphous P(3HB)s . It is known that P(3HB) exists in an amorphous state within the cell but that the extracted P(3HB) proceeds to crystallize (3, 4, 16) . Therefore, artificial amorphous P(3HB) granules were prepared and tested for the rebinding experiments in addition to crystalline P(3HB) granules . Figure 3 shows that PhaR has a high binding affinity toward P(3HB), because PhaR was enriched in the P(3HB) granule-associated fractions (lanes 3 and 4) from the lysate containing PhaR (lane 2) . Although increased concentrations of other proteins were detected for amorphous granules compared with the crystalline granules, the overall concentration of these other proteins was relatively low compared with that of PhaR . Even though the lysate without PhaR was used (lane 5), some proteins bound weakly to only the crystalline granules (lane 6) . Cytoplasmic proteins seemed to bind more tightly to amorphous granules than to crystalline granules (lane 6 and 7) . These observations suggest that PhaR would bind to P(3HB) granules without discriminating between the two different biophysical states of P(3HB) (crystalline or amorphous) . The ability of PhaR to bind P(3HB) was further confirmed by using the purified PhaR (data not shown) . Results from Fig . 1 to 3 clearly demonstrate that PhaR binds not only to DNA but also to P(3HB) .
Addition of PhaR to the assay mixture changed the electrophoretic mobility of PhaR-DNA225 and PhaR-DNA639 templates . The PhaR-DNA template complexes were seen as shifted bands in the upper region of the gel (Fig . 4, lane 2) . An increase in the amount of crystalline P(3HB) granules in the mixture disrupted the complexes, resulting in free DNA (lanes 3 to 6) . After PhaR-DNA complexes were formed, subsequent addition of crystalline P(3HB) granules to the mixture also caused dissociation of PhaR from the PhaR-DNA complexes (lane 7) . The 3HB oligomers (approximately 30-mer) and artificial amorphous P(3HB) granules also inhibited the formation of PhaR-DNA complexes (lanes 8 to 9) . Interestingly, neither native P(3HB) granules purified from E . coli XL1-Blue(pBBRKmAB pTVCP4) (harboring phaAB and phaCPR) nor native P(3HV) granules from P . denitrificans, which are predominantly covered with PhaP (Fig . 2A, lanes 7 and 10), inhibited the formation of PhaR-DNA complexes (lanes 10 to 11) . These results suggest that PhaR is able to sense both the onset of PHA synthesis and the growing size of the granules through the direct binding of PhaR to PHA, and that free PhaR does not sufficiently sense the mature PHA granules which are already covered with PhaP . P(3HB) granules purified from E . coli XL1-Blue(pBBRKmAB pTVC) (harboring phaAB and phaC) also caused no effect on the formation of PhaR-DNA complexes (data not shown) . The granules were covered nonspecifically with numerous endogenous cellular proteins (Fig . 2A, lane 4) . These results indicate that a naked PHA polymer chain and/or surface is needed to dissociate the PhaR-DNA complexes . To test whether other metabolites could be effector molecules for PhaR, the following substances possibly related to PHA synthesis were applied to the gel mobility shift assay: CoA-SH, acetyl-CoA, acetoacetyl-CoA, (R)-3-hydroxybutyryl-CoA, (S)-3-hydroxybutyryl-CoA, (rac)-3HB, (R)-3HB dimer, NAD+, NADH, NADP+, NADPH, acetyl phosphate (29), polyphosphate (6, 13, 37), citric acid, and phosphoenolpyruvate . Partially purified PhaP was also used in this assay . However, none of these substances had an effect on the binding of PhaR to DNA (results not shown), indicating that these metabolites and PhaP do not participate in the PhaR-mediated regulation as effector molecule for PhaR . Therefore, it was concluded that the effector of PhaR is P(3HB) .
PhaR is a repressor protein that derepresses phaP expression in response to P(3HB).
The effect of P(3HB) on phaP expression in the presence of PhaR was investigated by cell-free protein synthesis using E . coli S30 extract . As shown in Fig . 5, PhaP production (
PhaR, which we have characterized here, is a new type of protein belonging to class IV . In addition to our previous studies (24, 26), we provide here insights into important aspects of the regulatory mechanism for PHA synthesis through PhaR-mediated PhaP expression . First, PhaP expression in vivo is repressed in the presence of phaR without P(3HB) production (26) . Second, PhaR is a DNA-binding protein that represses PhaP expression in vitro (24) . Third, we demonstrated in this study that PhaR is a PHA-responsive protein that can bind PHA both in vivo and in vitro . These data indicate that PhaR has bifunctional characteristics, namely, binding abilities toward both PHA and DNA . Furthermore, we could argue that P(3HB) itself is an effector molecule for PhaR-mediated PhaP expression in a cell-free protein synthesis system (Fig . 5) . PhaR, to our knowledge, is the first regulator protein that interacts directly with the PHA polymer . The recognition requirement for this interaction was relatively nonspecific, because PhaR bound to all forms of P(3HB) usedcrystalline, amorphous, and 3HB oligomers . Based on these findings, a plausible model of the involvement of PhaR in PHA biosynthesis can be drawn (Fig . 6) . The phaC locus of P . denitrificans consists of four genes, phaZ, phaC, phaP, and phaR, that encode an intracellular PHA depolymerase, a PHA synthase, a phasin, and a PHA-responsive repressor PhaR, respectively (Fig . 6A) . Although the regulatory mechanisms for phaC and phaZ expression are not clear, phaC seems to be expressed constitutively (data not shown) . When an insufficient amount of substrates are provided for PHA biosynthesis (Fig . 6B), the cells are not able to accumulate PHA even if PhaC is produced sufficiently . At the same time, the expression of phaP and phaR remains at basal level, and PhaR binds to the upstream elements in IRCP and IRPR . Since PhaP is a predominant PHA granule-associated protein, PhaP production is not needed for the cells without PHA accumulation . Under this condition, PhaP production is repressed by PhaR through the direct binding of PhaR to the upstream element for phaP . Excessive PhaR production is also repressed by PhaR autoregulation . If sufficient substrates for PHA synthase are supplied (Fig . 6C), the cells begin to accumulate PHA . PhaR recognizes and binds directly to the PHA polymer chains being synthesized, and then the expression of PhaP is initiated at the onset of dissociation of PhaR from the upstream element for phaP . During the elongation of PHA polymer chains, the PHA granules enlarge in size, and then the surfaces of PHA granules become covered with PhaP and other specific proteins before the other nonspecific proteins bind to the PHA granules . Based on the fact that the phaP promoter is very strong (24), a number of PhaP molecules are expected to be produced under these conditions . When PHA synthesis is stopped or when PHA degradation occurs predominantly (Fig . 6D), free PhaR molecules bind to the upstream elements and repress both phaP expression and phaR expression . Accordingly, we assume that PhaR functions as a sensor for PHA synthesis in the cells . In the PhaR-mediated regulatory mechanism, it remains unclear whether there is any other factor(s) that forces PhaR to dissociate from the PhaR-PHA complex .
In order to examine whether PhaR homologs are widely distributed among SCL PHA-producing bacteria, we searched for the nucleotide sequences potentially coding for PhaR homologs among GenBank, EMBL, and DDBJ and several unfinished microbial genome databases available on the internet (see Material and Methods) by using the BLAST program (1) . To estimate whether a bacterium potentially carrying a PhaR homolog is a PHA producer, the genes coding for proteins similar to PHA synthases were searched simultaneously . At present, 31 structural genes for PhaR homologs have been found . Molecular phylogenetic analysis of PhaR homologs has revealed that the PhaR family has two main clusters, the first consisting of bacteria belonging to the
Prieto et al . (35) reported that two major MCL PHA granule-associated proteins, PhaF and PhaI, were found in Pseudomonas oleovorans, which possesses type II PHA synthases (43) . PhaF (35 kDa) is a nonenzymatic protein considered to have bifunctional characteristics . PhaF, like PhaR, is able to bind to both PHA granules and DNA . PhaF has been shown to be involved in transcriptional regulation of phaC genes and phaI (35), although direct evidence for binding of PhaF with DNA in vitro has not been obtained . PhaI (18 kDa) has also been confirmed to have PHA granule-binding ability in vivo . However, the deduced amino acid sequence of PhaR showed no similarity to that of either PhaF or PhaI . In addition, PhaD, which is not associated with PHA granules, was identified as a regulator protein positively affecting MCL PHA synthesis and PhaI production (18) . Identification of a characteristic gene cluster, phaC1ZC2DFI, in two other strains of Pseudomonas (P . putida [48] and P . aeruginosa [44]) suggests that the PHA synthesis regulation governed by these genes is commonly distributed in MCL PHA-producing pseudomonads . The regulatory system of MCL PHA synthesis thus seems to be more complicated than that of SCL-PHA synthesis . Povolo and Casella (34) showed that a mutant of Sinorhizobium meliloti that was defective in a phaR homolog aniA produced a larger amount of extracellular polymers, such as polysaccharides, than the wild-type strain under anoxic condition . The aniA gene is located upstream of phaAB in the opposite orientation (34, 46) . They demonstrated that aniA is inducible under anaerobic conditions but that the defect of aniA causes little effect on P(3HB) synthesis . Therefore, a direct role of aniA in the P(3HB) biosynthetic pathway is not clear (34) . York et al . (54) also recently reported the possibility that the PhaR from R . eutropha is involved in the regulation of PHA synthesis through PhaP-independent pathways . The findings obtained by us, Povolo et al., and York et al . raise the possibility that the PhaR-mediated regulatory system recognizing PHA accumulated in cells is involved not only in the expression of phaP but also in the expression of genes related to other metabolic pathways, namely, that PhaR may act as a PHA-responsive global repressor .
This work was supported by a grant for Ecomolecular Science Research, by a Grant-in-aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan, and by the Special Postdoctoral Researchers Program of the RIKEN Institute .
What Is Protein?,
What Is Genetics?,
What Is Growth Medium?,
What Is Environmental Microbiology?,
What Is Antibiotic?,
r,
Bacteria,
i,
Microorganisms,
i,
Microorganism,
r,
Microbes,
s,
Microbiology,
a,
S. cerevisiae,
r,
Bacillus,
i,
Bacillus subtilis,
o,
Bacillus anthracis,
c,
Escherichia coli,
n,
Cell suspensions,
n,
Escherichia coli,
a,
Yeasts,
c,
Escherichia coli,
i,
Amikacin,
i,
Clostridia,
o,
Enterobacteriacea,
a,
Bactericidal,
i,
Biofilms,
n,
Microorganism,
s,
E coli O157,
e,
Bacteria,
n,
Anaerobes,
a,
Eutrophicated,
s,
Streptococcal,
i,
Prokaryotes
|
© 2005
Transgalactic Ltd (manufacturer of Bioscreen C software) |
Privacy Statement | P.O. Box
1393, 00101 Helsinki, Finland,
Last modified: May 25, 2005
| ||||||